欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3183/005
药品名称LCE 150 mg/37,5 mg/200 mg, film-coated tablets
活性成分
    • carbidopa 43.75 mg
    • entacapone 200.0 mg
    • levodopa 175.0 mg
剂型Film-coated tablet
上市许可持有人Generics [UK] Limited Station Close, Potters Bar, Herfordshire EN6 1TL United Kingdom
参考成员国 - 产品名称Netherlands (NL)
Levodopa/Carbidopa/Entacapone Mylan 150/37.5/200 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Czechia (CZ)
      LEVODOPA/CARBIDOPA/ENTACPONE MYLAN 150/37.5/200 mg, potahované tablety
    • Greece (GR)
      LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN
    • Spain (ES)
    • France (FR)
    • Ireland (IE)
    • Italy (IT)
    • Slovakia (SK)
      Levodopa/Carbidopa/Entacapone Mylan 150/37,5/200 mg
    • United Kingdom (GB)
许可日期2014/10/01
最近更新日期2014/10/02
药物ATC编码
    • N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase